Literature DB >> 31744153

In Silico Molecular Studies of Antiophidic Properties of the Amazonian Tree Cordia nodosa Lam.

Carmen X Luzuriaga-Quichimbo1, José Blanco-Salas2, Luz María Muñoz-Centeno3, Rafael Peláez4, Carlos E Cerón-Martínez5, Trinidad Ruiz-Téllez2.   

Abstract

We carried out surveys on the use of Cordia nodosa Lam. in the jungles of Bobonaza (Ecuador). We documented this knowledge to prevent its loss under the Framework of the Convention on Biological Diversity and the Nagoya Protocol. We conducted bibliographic research and identified quercetrin as a significant bioactive molecule. We studied its in silico biological activity. The selected methodology was virtual docking experiments with the proteins responsible for the venomous action of snakes. The molecular structures of quercetrin and 21 selected toxins underwent corresponding tests with SwissDock and Chimera software. The results point to support its antiophidic use. They show reasonable geometries and a binding free energy of -7 to -10.03 kcal/mol. The most favorable values were obtained for the venom of the Asian snake Naja atra (5Z2G, -10.03 kcal/mol). Good results were also obtained from the venom of the Latin American Bothrops pirajai (3CYL, -9.71 kcal/mol) and that of Ecuadorian Bothrops asper snakes (5TFV, -9.47 kcal/mol) and Bothrops atrox (5TS5, -9.49 kcal/mol). In the 5Z2G and 5TS5 L-amino acid oxidases, quercetrin binds in a pocket adjacent to the FAD cofactor, while in the myotoxic homologues of PLA2, 3CYL and 5TFV, it joins in the hydrophobic channel formed when oligomerizing, in the first one similar to α-tocopherol. This study presents a case demonstration of the potential of bioinformatic tools in the validation process of ethnobotanical phytopharmaceuticals and how in silico methods are becoming increasingly useful for sustainable drug discovery.

Entities:  

Keywords:  Cordia; antiophidic; docking; in silico; quercetrin; validation

Mesh:

Substances:

Year:  2019        PMID: 31744153      PMCID: PMC6891429          DOI: 10.3390/molecules24224160

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Cordia is a tropical genus of arbustive Boraginaceae and is quite interesting from a pharmacological point of view [1]. More than thirty species are referenced as medicinal [2], having bioactive compounds such as rosmarinic acid, cordiaquinones and cordiachromes [3,4]. Cordia alliodora Cham., one of the most important timber trees in the Amazon, has an interesting chemical profile [5,6,7,8,9,10,11] with antimicrobial, antifungal, larvicidal [12] and cytotoxic activities [13] which have been experimentally tested. Cordia verbenaceae DC has been studied as anti-inflammatory [14], analgesic [15], antibacterial [16], antiallergic [17] and antitumoral [18]; the latter activity is attributed to the rosmarinic acid (Figure 1) [19].
Figure 1

Rosmarinic acid.

Another Cordia with promising properties is Cordia nodosa Lam, (= Cordia collococa Aubl [20]) a Pan-Amazonian species that contains [13] quercetrin (Figure 2), a strong antiproliferative in vitro.
Figure 2

Quercetrin.

In Amazonian Ecuador, many ethnic groups (cofan, redwood, siona, wao, shuar, achuar and kichwa) have reported references to the ancestral use [21]. The fruit is edible, the wood is employed for the construction of their houses in the jungle, and cultural ceremonies and rites are prepared with the leaves [21]. Cordia nodosa Lam contains phenols that justify its anti-inflammatory and analgesic applications and its moderate bactericidal action [22]. However, the most interesting ancestral knowledge of this plant is its ability to act as an antidote to snake bites [23]. This problem, seldom considered in Europe, affects millions of inhabitants of tropical areas of the planet and has not developed a pharmaceutical research according to its dimension [24]. Every year, about 5.4 million snake bites produce 1.8–2.7 million cases of poisoning, 81,410–137,880 deaths and about three times as many amputations and other permanent disabilities [24]. The World Health Organization has included snake bites in the category of “Neglected and Forgotten Diseases” [24]. In the context of ethnobotanical research conducted by our team in the Ecuadorian Amazon [21], we carried out surveys on the use of C. nodosa under the Framework of the Convention on Biological Diversity and the Nagoya Protocol [25]. We had two specific aims: (a) to describe the current use as an antivenom of C. nodosa in the Bobonaza Basin (Pastaza, Ecuador) and (b) to offer an in silico validation by searching the scientific literature and by overall performing docking tests.

2. Results

2.1. Ethnobotanical Survey

The medicinal uses given to the species retrieved from our fieldwork prospections and literature review are summarized in Table 1, which shows that the use of C. nodosa as an antiophidic is currently in force in indigenous Amazonian ethnic groups. Names like kuchamanku, awas, putunmuyu, machakuymisunsal or machakuykaspi have been published previously, but not paluwapu (“= snake stick”), which we learned from the canelo-kichwas cultures of Pastaza that we worked with [21]. We found that when a snake bite occurs, they take the bark, cook it for about one minute, and then drink the resulting liquid in a single dose.
Table 1

Medicinal uses given to the species retrieved from our fieldwork prospections and literature review.

Organ/SystemPart UsedFormulationTraditional KnowledgeEthnic Group-Province (Country)Reference
Circulatory systemleavesdecoctionhypertensionAmerindian NorthWest District (Guiana)[26]
Digestive systemgasesSiona-Sucumbíos (Ecuador)[23]
Respiratory systembarkcookingtreat coughSecoya-Sucumbíos (Ecuador)[23]
stem
inner barkfinely grate and decoctioncold and shortness of breathAmerindian (French Guiana)[26]
leavesdecoctionwhooping coughAmerindian NorthWest District (Guiana)[26]
fruitsucksnot in babiesAmerindian NorthWest District (Guiana)[26]
Musculature and skeletonleavescrush the leaves and rub the body with themrheumatism, sprains, muscle aches, bruisesAmerindian NorthWest District (Guiana)[26]
Nervous system and mental illnessleavesbaths with the decoction of the leavesmadness and psychiatric disordersYanesha (Perú)[27]
decoctionheadacheAmerindian NorthWest District (Guiana)[26]
Symptoms and states of undefined originbarkindeterminate conditionsSecoya-Sucumbíos (Ecuador)[23]
flowersKichwa del Oriente-Orellana (Ecuador)
fruitenergizingWao-Orellana (Ecuador)
leavesinfusiondizzinessethnicity not specified-Napo (Ecuador)
decoctionfeverAmerindian NorthWest District (Guiana)[26]
Poisoningleavesapply directly in the affected placespider bite, to decrease inflammation and prevent gangreneEast Kichwa-Napo and Orellana (Ecuador)[23]
fruit
plantcooking
barkcooking
rootcooking
barkscraped and in watersnake bites, to decrease inflammation and prevent gangreneEast Kichwa, Shuar-Napo, Orellana, Pastaza, Sucumbíos (Ecuador), Piaroa (Venezuela)[23,26]
infusion
rootinfusion
stemjuice
fruitjuice
young leaveschewed
leavesapply directly in the affected place

2.2. Chemical and Activity Prospection: Results of the Bibliographic Review

The main component of the extract was quercetrin, a 3α-l-rhamnoside of quercetin. The genine has a chemical structure based on a C6-C3-C6 carbon skeleton, with a chromene ring bearing a second aromatic ring at position 2. Therefore, it is a flavonoid, specifically a flavonol (Figure 2). This is a chemical group in which antiophidic properties are known [28]. The literature review performed is summarized in the following tables. It is known that snake venom comprises peptides and proteins that act as cytotoxins, neurotoxins, hemotoxins or myotoxins. The 21 molecular targets of snakebite poisonings, retrieved from our bibliographic research, are shown in Table 2.
Table 2

Toxins from Ecuadorian (1–2), Latin American (3–13) or non-American (14–21) snakes, and the corresponding Protein Data Base Identifier (PDB ID).

ToxinPDB IDReference
1. MT-I—Basic phospholipase a2 myotoxin iii5TFV[29]
2. LAAO—L-amino acid oxidase from Bothrops atrox5TS5[30]
3. PLA2—Phospholipase A2: Piratoxin I (myotoxic Lys49-PLA2) from Bothrops pirajai3CYL[31]
4. PLA2—Phospholipase A2: BthTX-I—Bothropstoxin I from Bothrops jararacussu venom/3CXI[31]
5. PLA2—Phospholipase A2: Myotoxin (MjTX-I) from Bothrops moojeni6CE2[32]
6. PLA2—Phospholipase A2: Bothropstoxin I (BthTX-I)6DIK[33]
7. svPLA2—Phospholipase A2: myotoxin II from Bothrops moojeni1XXS[34]
8. LAAO—L-amino acid oxidasefrom the B. jararacussu venom4E0V[35]
9. svPLA2—Acidic phospholipase A2 (BthA-I) from Bothrops jararacussu1Z76[36]
10. VRV-PL-V—Crotoxin B, the basic PLA2 from Crotalus durissusterrificus2QOG[37]
11. PLA2—Piratoxin-II (Prtx-II) - a K49 PLA2 from Bothrops pirajai1QLL[38]
12. Bothropasin, the Main Hemorrhagic Factor from Bothrops jararaca venom3DSL[39]
13. SVMP—P-I snake venom metalloproteinase BaP12W12[40]
14. NNH1—L-amino acid oxidase from venom of Naja atra5Z2G[41]
15. LAAO—L-amino acid oxidase from Vipera ammodytes venom3KVE[42]
16. PDE I—Phosphodiesterase (PDE) from Taiwan cobra (Naja atra atra) venom5GZ4[43]
17. VRV-PL-V—Phospholipase ACII4 from Australian King Brown Snake (Pseudechis australis)3V9M[44]
18. NN-PL-I—Phospholipase A2 from indian cobra (Naja naja)1PSH[45]
19. LAAO—L-amino acid oxidase from Agkistrodon Halys Pallas (Gloydius halys)1REO[46]
20. NNH1—Phosphodiesterase (PDE) fromTaiwan cobra (Naja atra atra)5GZ5[47]
21. PLA2—Phospholipase A2 (Pla2) from Naja naja1A3D[48,49]

2.3. Docking

The liaison energies of quercetrin with the studied targets are presented in Table 3. They have been colored by groups according to their similarity to the rest of the sequences (see Supplementary Material for details). They oscillate between −10.03 kcal/mol and −7.01 kcal/mol.
Table 3

The liaison energies of quercetrin with the PDB ID studied targets.

1. 5TFV−9.71MT-I—Basic Phospholipase a2 Myotoxin iii
2. 5TS5−9.47LAAO—L-amino acid oxidase from Bothrops atrox
3. 3CYL−9.49PLA2—Phospholipase A2: Piratoxin I (myotoxic Lys49-PLA2) from Bothrops pirajai
4. 3CXI−9.37PLA2—Phospholipase A2: BthTX-I—Bothropstoxin I from Bothrops jararacussu venom/
5. 4GUE−9.30N-terminal kinase domain of RSK2 with flavonoid glycoside quercetrin
6. 6CE2−9.19PLA2—Phospholipase A2: Myotoxin (MjTX-I) from Bothrops moojeni
7. 6DIK−9.16PLA2—Phospholipase A2: Bothropstoxin I (BthTX-I)
8. 1XXS−9.01svPLA2—Phospholipase A2: myotoxin II from Bothrops moojeni
9. 4E0V−8.96LAAO—L-amino acid oxidasefrom the B. jararacussu venom
10. 1Z76−8.56svPLA2—Acidic phospholipase A2 (BthA-I) from Bothrops jararacussu
11. 2QOG−8.32VRV-PL-V—Crotoxin B, the basic PLA2 from Crotalus durissusterrificus
12. 5A4W−8.28AtGSTF2 from Arabidopsis thaliana
13. 1QLL−8.23PLA2—Piratoxin-II (Prtx-II) - a K49 PLA2 from Bothrops pirajai
14. 3DSL−8.20Bothropasin, the Main Hemorrhagic Factor from Bothrops jararaca venom.
15. 2W12−7.71SVMP—P-I snake venom metalloproteinase BaP1
Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8, Figure 9, Figure 10, Figure 11, Figure 12, Figure 13, Figure 14 and Figure 15 show the molecular models of the quercetrin binding with the targets of Table 3 (left) and the corresponding 2D interaction diagram generated with LigPlot + (right) [50], made with UCSF Chimera Software. Toxins are represented in golden yellow, quercetrin in blue, and original ligands in pink. The small squares (a) show the toxin-quercetrin complex in the most favorable arrangement. When it occupies the hollow of another ligand present in the structure of the target, it has been preserved (shown as thin sticks in pink) to allow a comparison. The augmented figures (b) show, in detail, the dispositions of the quercetrin molecule between the chains of the toxins.
Figure 3

5TFV-quercetrin complex. in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 4

5TS5-quercetrin complex. in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 5

3CYL quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 6

3CXI-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 7

6CE2-q uercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 8

6DIK-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 9

1XXS-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 10

4E0V-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 11

1Z76-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 12

2QOG-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 13

1QLL-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 14

3DSL-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

Figure 15

2W12-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.

3. Discussion

The traditional use of this plant for its antiophidic properties has been previously documented by the Shuar and the Napo-Rune people of neighboring provinces, although the method of application is different. In these cases, the plant is applied directly to the affected place, or they chew the young leaves and the fruits. They also prepare infusions, not with the bark, but with the root or the juice of the stem [23]. Published references on the activity of quercetrin have indicated that it inhibits lipoxygenase svPLA2 [51] and hyaluronidase NNH1 [52], neutralizing the hemorrhagic venom of Bothrops jararaca [51,52,53], a Latin American snake. In the docking tests that we carried out, the toxic snakes studied showed very high affinities with quercetrin. There were formed complexes of energy comparable to the ones with original targets such as 4GEW or 5A4W. Detailed information about these protein homologies has been included in Appendix A (Table A1). Thus, reasonable binding free energy values of −7 to −10 kcal/mol were obtained. The most favorable values were for the venom of the Asian snake (Chinese cobra or Taiwan cobra) Naja atra (5Z2G, −10.03 kcal/mol) and the Latin American Bothrops pirajai (3CYL, −9.71 kcal/mol). Very good results were also found with the 5TFV of the Ecuadorian snakes Bothrops asper, (ΔG −9.47 kcal/mol) and 5TS5 of Bothrops atrox (ΔG −9.49 kcal/mol). Therefore, quercetrin can not only be used as an antiophid for Ecuadorian venomous snakes, but for many others.
Table A1

Similarity matrix for the target proteins. In each cell the upper number represents the percentage of identity and the lower the percentage of similarity for the protein in that row. The number in parenthesis represent the corresponding amino-acid number after Smith-Waterman comparison of the sequences. The cells are colored according to the percentage of similarity: <25% yellow, 25–50% orange, 50-75% green and >75% light blue. Diagonal cells with 100% identity are colored in dark blue. The protein IDs in the upper row have been colored by groups according to their similarity to the rest of the sequences.

4GUE(305)5A4W(212)1QLL(121)1XXS(122)1Z76(123)2QOG(122)2W12(202)3CXI(121)3CYL(121)3DSL(419)4E0V(497)5TFV(122)5TS5(484)6CE2(121)6DIK(121)
4GUE(305)100%2.95% (9)5.25% (16)1.64% (5)2.30% (7)1.64 % (5)2.95% (9)1.97 % (6)1.97 % (6)1.31% (4)1.31% (4)8.20% (25)14.10% (43)1.97% (6)2.95% (9)1.64% (5)2.30 % (7)5.90% (18)8.20% (25)8.52% (26)16.07 % (49)1.97% (6)3.28 % (10)6.23% (19)13.77% (42)1.31 % (4)1.64 % (5)1.97 % (6)2.95 % (9)
5A4W(212)4.25% (9)7.55% (16)1002.36% (5)2.83% (6)2.83% (6)4.72% (10)2.83% (6)4.25 % (9)3.77% (8)4.25% (9)6.60% (14)9.91% (21)2.36% (5)2.83% (6)2.62% (13)3.43% (17)4.25% (9)8.49% (18)19.81% (42)35.38% (75)2.36% (5)2.83% (6)19.81% (42)35.38% (75)5.19% (11)6.60% (14)2.36% (5)2.83% (6)
1QLL(121)4.13% (5)5.79 % (7)4.13 % (5)4.96 % (6)100%93.39% (113)95.04% (115)48.76% (59)70.25% (85)48.76% (59)62.81% (76)4.96% (6)7.44% (9)98.35% (119)99.17% (120)99.17% (120)99.17% (120)14.05% (17)21.49% (26)19.83 % (24)35.54 % (43)60.33% (73)71.07% (86)5.79 % (7)9.09 % (11)86.78% (105)89.26% (108)99.17% (120)99.17% (120)
1XXS(122)4.10% (5) 7.38%(9)4.92% (6)8.20% (10)92.62%(113) 94.26% (115)100%50.82% (62)69.67% (85)49.18% (60)63.11% (77)4.92% (6)7.38% (9)94.26% (115)95.08% (116)92.62% (113)94.26% (115)13.93% (17)21.31% (26)9.84% (12)16.39% (20)59.84% (73)69.67% (85)4.10% (5)5.74% (7)82.79% (101)85.25% (104)93.44% (114)95.08% (116)
1Z76(122)4.92% (6)4.92% (6)4.92% (6)7.38% (9)48.36% (59)69.67% (85)50.82% (62)69.67% (85)100%56.56% (69)66.39% (81)7.38% (9)9.02% (11)50.0 % (61)70.49% (86)48.36% (59)69.67% (85)18.85% (23)28.69% (35)8.20% (19)9.02% (11)56.56% (69)71.31% (87)8.20% (10)9.84% (12)50.00% (61)65.57% (80)49.18% (60)70.49% (86)
2QOG(122)3.28% (4)3.28% (4)6.56% (8)7.38% (9)48.36%(59) 62.30% (76)49.18% (60)63.11% (77)56.56% (69)66.39% (81)100%7.38% (9)10.66% (13)47.54% (58)62.30% (76)48.36% (59)62.30% (76)22.13% (27)28.69% (35)9.84% (12)18.03% (22)63.93% (78)76.23% (93)9.84% (12)18.03% (22)47.54% (58)57.38% (70)48.36% (59)62.30% (76)
2W12(202)12.38% (25)21.29% (43)6.93% (14)10.40% (21)2.97 % (6)4.46 % (9)2.97% (6)4.46% (9)4.46% (9)5.45% (11)4.46% (9)6.44% (13)100%2.97% (6)4.46% (9) 92.97% (6)4.46% (9)52.48% (106)67.82% (137)3.47% (7)5.45% (11)1.98% (4)2.97% (6)3.47% (7)5.45% (11)7.92% (16)12.87% (26)2.97% (6)4.46 % (9)
3CXI(121)4.96% (6)7.44% (9)4.13% (5)4.96% (6)98.35% (119)99.17 % (120)95.04% (115)95.87% (116)50.41% (61)71.07% (86)47.93% (58)62.81% (76)4.96% (6)7.44% (9)100%98.35% (119)99.17% (120)14.05% (17)21.49% (26)19.83% (24)34.71% (42)59.50% (72)70.25% (85)5.79% (7)9.09% (11)85.95% (104)89.26% (108)99.17% (120)100% (122)
3CYL(121)4.13% (5)5.79% (7)10.74% (13)14.05% (17t)99.17% (120)99.17% (120)93.39% (113)95.04% (115)48.76% (59)70.25% (85)48.76% (59)62.81 % (76)4.96% (6)7.44% (9)98.35% (119)99.17% (120)100%14.05% (17)21.49% (26)19.83% (24)35.54% (43)59.50% (72)70.25% (85)5.79% (7)9.09% (11)87.60% (106)90.08% (109)99.17% (120)99.17% (120)
3DSL(479)4.30% (18)5.97% (25)2.15% (9)4.30% (18)4.06% (17)6.21% (26)4.06% (26)6.21% (26)5.49% (23)8.35% (35)6.44% (35)8.35% (35)25.30% (106)32.70% (137)4.06% (17)6.21% (26)4.06% (17)6.21% (26100%2.39% (10)3.34 % (14)4.06% (17)5.97% (25)2.39% (10)3.58% (15)4.06% (17)6.68% (28)4.06% (17)6.21% (26)
4E0V(497)5.23% (26)9.86% (49)8.45% (42)15.09% (75)4.83% (24)8.65% (43)2.41% (12)4.02% (20)2.01% (19)2.21% (11)2.41% (12)4.43% (22)1.41% (7)2.21% (11)4.83% (24)8.45% (424.83% (24)8.65% (43)2.01% (10)2.82 % (14)100%3.22% (16)5.63% (28)95.37% (474)95.98% (477)2.41% (12)4.23% (21)4.83% (24)8.65% (43)
5TVF(122)4.92% (6)8.20% (10)4.10% (5)4.92% (6)59.84% (73)70.49% (86)59.84% (73)69.67% (85)56.56% (69)71.31% (87)63.93% (78)76.23% (93)3.28% (4)4.92% (6)59.02% (72)69.67% (85)59.02% (72)69.67% (85)13.93% (17)20.49% (25)13.11% (16)22.95% (28)100%13.11% (16)22.95% (28)56.56% (69)66.39% (81)59.02% (72)69.67% (85)
5TS5(484)3.93% (19)8.68% (42)8.68% (42)15.50% (75)1.45 % (7)2.27 % (11)1.03% (5)1.45% (7)2.07% (10)2.48% (12)2.48% (12)4.55% (22)1.45% (7)2.27% (11)1.45% (7)2.27% (11)1.45% (7)2.27% (11)2.07% (10)3.10% (15)97.93% (474)98.55% (477)3.31% (16)5.79% (28)100%2.48% (12)4.34% (21)1.45% (7)2.27% (11)
6CE2(121)3.31% (4)4.13% (5)9.09% (11)11.57% (14)86.78% (105)89.26% (108)83.47% (101)85.95% (104)50.41% (61)66.12% (80)47.93% (58)57.85% (70)13.22% (16)21.49% (26)85.95% (104)89.26% (108)87.60% (106)90.08% (109)14.05% (17)23.14% (28)9.92% (12)17.36% (21)57.02% (69)66.94% (81)9.92% (12)17.36% (21)100%86.78% (105)89.26% (108)
6DIK(121)4.96 % (6)7.44 % (9)4.13% (5)4.96% (6)99.17% (120)99.17% (120)94.21% (114)95.87% (116)49.59% (60)71.07% (86)48.76% (59)62.81% (76)4.96% (6)7.44 % (9)99.17% (120)100% (122)99.17% (120)99.17% (120)14.05% (17)21.49% (26)19.83% (43)35.54% (43)59.50% (72)70.25% (85)5.79% (7)9.09% (11)86.78% (105)89.26% (108)100%
The action can be expected to be effective, especially because, in addition, the models have not presented unfavorable interactions according to SwissDock scoring terms. On many occasions, the quercetrin molecule is placed in pockets that occupy other known ligands of the targets used in this study. This is the case for 3CYL and 3CXI (Figure 5b and Figure 6b), which occupy the pocket of α-tocopherol, 5TS5 (Figure 4b), which is close to that of FAD, 6CE2 (Figure 7b), that occupies that of suramin (a known inhibitor), 1XXS (Figure 9b), that of two stearic acids, 1QLL (Figure 13b), that of tridecanoic acid, and 2W12 (Figure 15b), which occupies the peptidomimetic inhibitor site. All of this reinforces the validity of the results of the performed docking tests. In the 5Z2G and 5TS5 L-amino acid oxidases, quercetrin binds in a pocket adjacent to the FAD cofactor, while in the myotoxic homologues of PLA2, 3CYL and 5TFV, it joins in the hydrophobic channel formed when oligomerizing in the first one, similar to α-tocopherol. These facts reinforce the validity of the traditional use reported. They will have to be corroborated in vitro, in vivo, and even with subsequent clinical trials. Nevertheless, this is encouraging evidence in the field of finding new solutions to this pathology.

4. Materials and Methods

4.1. Ethnobotanical Survey

All the information referring to the ethnobotanical study from which the data derives is available in Appendix A, which contains references to voucher specimens, authorizations and permissions. Table 1 summarizes the medicinal uses of the species retrieved from our fieldwork prospections and literature data.

4.2. Chemical and Activity Prospection: Bibliographic Review

A bibliographic review was carried out following the PRISMA Group method [54]. The databases accessed were Academic Search Complete, Agricola, Agris, Biosis, CABS, Cochrane, Cybertesis, Dialnet, Directory of Open Access Journals, Embase, Espacenet, Google Patents, Google Academics, Medline, PubMed, Science Direct, Scopus, Teseo, and ISI Web of Science. The selected citations were summarized, and a critical reading allowed us to develop the discussion.

4.3. Docking

The molecular docking method applied comprises the following procedures: ligand preparation, protein selection, docking, and analysis of the results. The energies produced after docking, interaction residues and interaction types were studied for the analyses following general procedure for molecular docking [55,56]. Docking was performed with the SwissDock Docking Web Service (Available online: http://www.loc.gov). A 3D quercetrin virtual structure was built with Spartan®, Wavefunction Inc. Selection of targets was made based on a bibliographic review of natural bioactive compounds against snake bites [28,54]. A total of 21 venoms from snakes (targets) with known X-ray structures were tested (see Table 2, Table 3 and Supplementary Material). Molecular structures were consulted in the Protein Data Bank (PDB), and the reference IDs were taken to include them in the Swiss Dock Program. The target + ligand set was considered stable when the values of the binding free energy were lower than −7 kcal/mol. This consideration is based on docking experiments with the known X-ray structures 4GUE and 5A4W complexes of quercetrin resulting in binding energies values of −9.30 and −8.28 kcal/mol, respectively. Once the results of the docking were obtained, they were analyzed with UCSF Chimera.

5. Conclusions

The information obtained from the ethnobotanical investigations carried out in the Bobonaza Basin (Ecuador) allowed us to verify the good capacity in silico of quercetrin, the active ingredient obtained from Cordia nodosa. The binding energies of quercetrin with all the macromolecules (toxins from venoms of different snakes) were adequate, since they were all less than −7 kcal/mol. The in silico docking evaluation combined with ethnobotanical information was very effective as a research method. It allowed us to select the appropriate active principle from the beginning, thus avoiding the tedious previous work of testing principle assets that have no references and therefore working blindly with molecules that would not couple to these toxins. The search for new bio-products oriented from basic ethnobotanical knowledge is an investigation that could result in products with great therapeutic efficacies.
  31 in total

1.  Purification, partial characterization, crystallization and structural determination of AHP-LAAO, a novel L-amino-acid oxidase with cell apoptosis-inducing activity from Agkistrodon halys pallas venom.

Authors:  Hongmin Zhang; Maikun Teng; Liwen Niu; Yubao Wang; Yuzhen Wang; Qun Liu; Qingqiu Huang; Quan Hao; Yuhui Dong; Peng Liu
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-04-21

2.  Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction.

Authors:  Fábio K Ticli; Lorane I S Hage; Rafael S Cambraia; Paulo S Pereira; Angelo J Magro; Marcos R M Fontes; Rodrigo G Stábeli; José R Giglio; Suzelei C França; Andreimar M Soares; Suely V Sampaio
Journal:  Toxicon       Date:  2005-09-01       Impact factor: 3.033

3.  Chemical constituents from Cordia alliodora and C. colloccoca (Boraginaceae) and their biological activities.

Authors:  Myrto Maria Fouseki; Harilaos Damianakos; George Albert Karikas; Christos Roussakis; Mahabir P Gupta; Ioanna Chinou
Journal:  Fitoterapia       Date:  2016-09-20       Impact factor: 2.882

4.  Inhibition of Naja naja venom hyaluronidase: role in the management of poisonous bite.

Authors:  K S Girish; K Kemparaju
Journal:  Life Sci       Date:  2005-10-25       Impact factor: 5.037

5.  Structural insights for fatty acid binding in a Lys49-phospholipase A2: crystal structure of myotoxin II from Bothrops moojeni complexed with stearic acid.

Authors:  Leandra Watanabe; Andreimar M Soares; Richard J Ward; Marcos R M Fontes; Raghuvir K Arni
Journal:  Biochimie       Date:  2005-02       Impact factor: 4.079

6.  Triacontyl p-coumarate: an inhibitor of snake venom metalloproteinases.

Authors:  M M Mendes; S A P B Vieira; M S R Gomes; V F Paula; T M Alcântara; M I Homsi-Brandeburgo; J I dos Santos; A J Magro; M R M Fontes; V M Rodrigues
Journal:  Phytochemistry       Date:  2012-11-08       Impact factor: 4.072

7.  Cordia verbenacea and secretion of mast cells in different animal species.

Authors:  Déborah Mara Costa de Oliveira; Ana Carolina Luchini; Leonardo Noboru Seito; José Carlos Gomes; María Elena Crespo-López; Luiz Claudio Di Stasi
Journal:  J Ethnopharmacol       Date:  2011-03-29       Impact factor: 4.360

8.  Structural basis for low catalytic activity in Lys49 phospholipases A2--a hypothesis: the crystal structure of piratoxin II complexed to fatty acid.

Authors:  W H Lee; M T da Silva Giotto; S Marangoni; M H Toyama; I Polikarpov; R C Garratt
Journal:  Biochemistry       Date:  2001-01-09       Impact factor: 3.162

9.  Structures of two novel crystal forms of Naja naja naja phospholipase A2 lacking Ca2+ reveal trimeric packing.

Authors:  B W Segelke; D Nguyen; R Chee; N H Xuong; E A Dennis
Journal:  J Mol Biol       Date:  1998-05-29       Impact factor: 5.469

10.  Structural and functional characterization of suramin-bound MjTX-I from Bothrops moojeni suggests a particular myotoxic mechanism.

Authors:  Guilherme H M Salvador; Thiago R Dreyer; Antoniel A S Gomes; Walter L G Cavalcante; Juliana I Dos Santos; César A Gandin; Mário de Oliveira Neto; Márcia Gallacci; Marcos R M Fontes
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.